Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Sipos

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Acta Haematologica|October 19, 2011
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patientsNóra Meggyesi, András Kozma, Gabriella Halm, et al.
Leukemia & Lymphoma|October 5, 2013
Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohortMagdalena Koszarska, Nora Meggyesi, Andras Bors, et al.
Haematologica|July 28, 2011
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemiaSarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, et al.
Leukemia & Lymphoma|October 9, 2012
Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemiaMagdalena Koszarska, Andras Bors, Angela Feczko, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Acta Haematologica|October 19, 2011
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patientsNóra Meggyesi, András Kozma, Gabriella Halm, et al.
Leukemia & Lymphoma|October 5, 2013
Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohortMagdalena Koszarska, Nora Meggyesi, Andras Bors, et al.
Haematologica|July 28, 2011
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemiaSarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, et al.
Leukemia & Lymphoma|October 9, 2012
Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemiaMagdalena Koszarska, Andras Bors, Angela Feczko, et al.
Pageof 2